151 related articles for article (PubMed ID: 33976110)
1. Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands.
Posthuma HLA; Zijlstra JM; Visser O; Kersten MJ; Lugtenburg PJ; Dinmohamed AG
Blood Cancer J; 2021 May; 11(5):87. PubMed ID: 33976110
[No Abstract] [Full Text] [Related]
2. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
3. Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.
Posthuma HLA; Zijlstra JM; Visser O; Lugtenburg PJ; Kersten MJ; Dinmohamed AG
Br J Haematol; 2020 Apr; 189(1):117-121. PubMed ID: 31682006
[TBL] [Abstract][Full Text] [Related]
4. Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.
Molin D; Linderoth J; Wahlin BE
Br J Haematol; 2017 May; 177(3):449-456. PubMed ID: 28233899
[TBL] [Abstract][Full Text] [Related]
5. Paediatric lymphocyte-predominant Hodgkin's lymphoma.
Burki TK
Lancet Oncol; 2016 Jul; 17(7):e272. PubMed ID: 27237611
[No Abstract] [Full Text] [Related]
6. Nodular lymphocyte predominant Hodgkin lymphoma in USA between 2000 and 2014: an updated analysis based on the SEER data.
Shivarov V; Ivanova M
Br J Haematol; 2018 Sep; 182(5):727-730. PubMed ID: 28737250
[No Abstract] [Full Text] [Related]
7. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.
Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH
Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883
[TBL] [Abstract][Full Text] [Related]
8. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.
Uherova P; Olson S; Thompson MA; Juskevicius R; Hamilton KS
Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):105-10. PubMed ID: 15354734
[TBL] [Abstract][Full Text] [Related]
10. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Br J Haematol; 2014 Oct; 167(2):238-42. PubMed ID: 24965443
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin lymphoma involving extranodal sites in head and neck: report of twenty-nine cases and review of three-hundred and fifty-seven cases.
Akhtar S; Khafaga Y; Edesa W; Al-Mubarak M; Rauf MS; Maghfoor I
Hematology; 2021 Dec; 26(1):103-110. PubMed ID: 33478377
[TBL] [Abstract][Full Text] [Related]
12. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
[TBL] [Abstract][Full Text] [Related]
13. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution.
Kenderian SS; Habermann TM; Macon WR; Ristow KM; Ansell SM; Colgan JP; Johnston PB; Inwards DJ; Markovic SN; Micallef IN; Thompson CA; Porrata LF; Martenson JA; Witzig TE; Nowakowski GS
Blood; 2016 Apr; 127(16):1960-6. PubMed ID: 26837698
[TBL] [Abstract][Full Text] [Related]
14. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
15. [Changing patterns in the clinical, pathological features of Hodgkin lymphoma].
Miltényi Z; Simon Z; Páyer E; Váróczy L; Gergely L; Jóna A; Illés A
Orv Hetil; 2010 Dec; 151(49):2011-8. PubMed ID: 21106481
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
[No Abstract] [Full Text] [Related]
17. Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group.
Eichenauer DA; Plütschow A; Schröder L; Fuchs M; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
Blood; 2018 Oct; 132(14):1519-1525. PubMed ID: 30064977
[TBL] [Abstract][Full Text] [Related]
18. Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis.
Xing KH; Connors JM; Lai A; Al-Mansour M; Sehn LH; Villa D; Klasa R; Shenkier T; Gascoyne RD; Skinnider B; Savage KJ
Blood; 2014 Jun; 123(23):3567-73. PubMed ID: 24713929
[TBL] [Abstract][Full Text] [Related]
19. Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.
Savage KJ; Skinnider B; Al-Mansour M; Sehn LH; Gascoyne RD; Connors JM
Blood; 2011 Oct; 118(17):4585-90. PubMed ID: 21873543
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
